Smith and Nephew and Nanotope agree to collaborate on development of Cartilage Regeneration Technology |

Smith and Nephew and Nanotope agree to collaborate on development of Cartilage Regeneration Technology

Arrowhead Portfolio Company, Nanotope, Inc. Enters Agreement with Smith & Nephew for the License and Development of Cartilage Regeneration Technology (Press Release)

Nanotope website – Nanotope is developing a suite of products, each customized to regenerate specific tissues; including neuronal, vascular, bone, myocardial, and cartilage. The products are injectable compounds that work with surviving cells in and around the point of damage to initiate and support tissue regeneration and growth. Once regeneration is complete, the compounds are safely broken down and removed by the body.regeneration and growth. Once regeneration is complete, the compounds are safely broken down and removed by the body. Nanotope is positioned to enter into a commercialization corporate partnership in 2010 and expects to be able to start a first round of clinical trials in 2010.

Leave a Reply

Your email address will not be published. Required fields are marked *